• Camlin Fine Sciences board meeting scheduled for May 26, 2026, to approve Q4 and FY26 audited financial results.
• Trading window for company equity shares closed from April 1, 2026, until 48 hours after results publication.
• Regulatory intimation made pursuant to SEBI LODR Regulations, specifically Regulation 29.